Overall, we have delivered just short of 50 asset/portfolio valuations that have been used for asset licensing, company acquisition, investment negotiation and preparation for IPOs. However, we have probably done at least twice as many market opportunity analysis projects covering everything from immuno-oncology, rare diseases, cell & gene therapies, specific receptor target landscapes, point-of-care technologies, RNA platforms, CROs/CDMOs, investors, Big Pharma portfolio strategies and much more.
It is fair to say that we are Life Science generalists specialized in business development, valuation and communication in the Nordics. Our ambition is to maintain a healthy mix of long-term partnerships and shorter client engagements. We thrive when our clients succeed.
Why do our clients keep coming back?
It is simple, because of our team! We are a diverse bunch of ambitious, hard-working and energetic people with a fervor for the Life Science industry. While we come from different backgrounds, we share a passion with our clients to drive the future of medicine.
We are Monocl Strategy & Communication

Tobias Thornblad
CEO & Partner

Tove Bergenholt
COO & Communication Director

Julia Fransson
Project Director

Björn Carlsson
Partner

Okee Williams
Senior Management Consultant

Jihua Liu
Senior Management Consultant

Paola Jo
Management Consultant

Sofie Lyck
Intern

Paula Salme Sandrak
Management Consultant

Axel Desaix
Business Analyst

Robert Ljungberg
Business Analyst

Linnea Forssell
Communication Associate

Anna Olsson
Communication Intern

Shadali Singh
Analyst Intern

Monika Vedin
Senior External Consultant
